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CLINICAL PROFILE AND SEVERITY OF 
STROKE IN DIABETIC AND NON-
DIABETIC PATIENTS 
INTRODUCTION 
 
     Stroke which is defined as abrupt onset of a neurological deficit that 
is attributable to a vascular cause, is the major cause of death 
worldwide. Stroke is the second most common cause of death and also 
the leading cause of long-term disability worldwide
1
 . Various risk 
factors  are known to increase the liability of stroke and its outcome, of 
which the most important being Diabetes, Hypertension, Smoking and 
Dyslipidemia. Diabetes mellitus is a group of metabolic disorders with 
vascular complications. 
      Diabetes mellitus is a well established independent risk factor for 
ischemic stroke with an overall risk of 2.5 times higher than in non- 
diabetic patients and is associated with greater in- hospital mortaliy and 
morbidity in both ischaemic stroke and intracerebral haemorrhage. In 
our country the estimated prevalence rate of stroke range, 84-262 per 
lakh population  in rural and 334-424per lakh population in urban 
areas
2
. The incidence rate is 119-145per lakh population based on the 
recent population based studies
2
. This study mainly focused on severity 
of stroke in diabetic patients who admitted in tirunelveli medical 
college hospital. 
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           The modifiable risk factor like systemic hypertension ,diabetes 
mellitus , life style factors such as smoking , excessive alcohol intake , 
stress , high fat diet ,sedentary life style increase the incidence of 
stroke. 
          The increasing number of diabetic patients in our country 
increases the number of noncommunicable disease among our 
population. Diabetes mellitus alters the lipid metabolism and promotes 
the formation of atheroma. Also the diabetic partients has other 
associated risk factors more commonly than non diabetics. All these 
factors increases the incidence and severity of cerebrovascular disease 
among diabetes patients.  
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Aim of the study: 
 
1. To study the presentation of symptoms of stroke  in diabetic 
patients. 
2.  To study the relationship between hyperglycemia on admission 
  and severity  of stroke in diabetic patients. 
3.   To study the severity of symptoms and signs of stroke in diabetic   
  and non- diabetic patients. 
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Review of literature 
  
BLOOD SUPPLY OF BRAIN :  
Brain gets its arterial supply  from 2 pairs of vessels. The vertebral 
which forms the posterior circulation and internal carotid arteries which 
forms the anterior circulation. Both are interconnected in cranial cavity 
and produce circle of willis. 
Anterior cerebral circulation 
 
                The  Internal carotid artery is the branch of  common carotid 
artery. They proceed superiorly enter in to the cranial cavity through 
carotid canal. By entering the cranial cavity each of the internal carotid 
artery gives off , the anterior cerebral artery , the middle cerebral artery 
and the posterior communicating artery , the ophthalmic artery. 
       Anterior cerebral artery supplies the entire medial surface of  
cerebral hemisphere including a strip of cortex for about 2 cm along the 
superolateral surface and medial half of orbital surface except the 
occipital lobe. Recurrent artery of heubner is an important branch of 
ACA and its involvement causes faciobrachial monoplegia. 
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Middle cerebral artery supplies the entire lateral surface of cerebrum 
including lateral half of orbital surface except, frontalpole and a strip of 
cortex for about 2cm along superolateral surface of frontal lobe , 
Medial half of orbital surface , lower temporal and occipital pole. 
Posterior cerebral artery supplies the medial surface of temporal and 
occipital lobes and their tentorial surface. It also supplies cerebellum , 
medulla , pons , midbrain , subthalamus and thalamus. 
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                  Above picture shows BLOOD SUPPLY BY MCA 
 
Posterior cerebral circulation: 
Vertebral arteries : 
               Vertebral artery arises from first part of subclavian artery. 
Enters the cranial cavity through foramen magnum, each vertebral 
artery gives small meningeal branch. Vertebral artery gives 3 additional 
branch, 
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1. Anterior spinal artery 
2. Posterior spinal artery 
3. posterior inferior cerebellar artery. 
Vertebral artery on each side joins to form basilar artery. Its branches in 
a caudal to rostral direction anterior inferior cerebellar arteries, several 
small pontine arteries,superior cerebellar arteries.basilar artery 
bifurcates into posterior cerebral arteries. 
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CIRCLE OF WILLIS: 
 
     Cerebral arterial circle is formed at the base of the brain by the 
interconnecting vertebrobasilar and internal carotid systems of arteries. 
This interconnections achived by an anterior communicating artery 
which interconnects left and right anterior cerebral arteries, 2 posterior 
communicating arteries one on each side connects posterior cerebral 
artery with the internal carotid artery. 
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INTERNAL CAPSULE: 
  The anterior limb of internal capsule is bounded medially by the head 
of the caudate nucleus and laterally by the lentiform nucleus. Genu of 
the internal capsule lies at the most medial edge of the globus pallidus. 
Posterior limb of internal capsule is bounded medially by the thalamus 
and laterally by the lentiform nucleus. Corticonuclear fibers which are 
motor fibers from the cerebral cortex to the motor nuclei of the cranial 
fibers pass through the genu of internal capsule. Corticospinal fibers 
pass through the anterior two third of the posterior limb of the internal 
capsule. Genu and posterior limb of the internal capsule is supplied by 
the striate branches of the anterior and middle cerebral arteries. 
DIABETES MELLITUS: 
 
Diabetes mellitus is a group of metabolic disorders characterised by 
chronic hyperglycemia associated with disturbances of carbohydrate 
metabolism, protein metabolism and fat metabolism due to absolute or 
relative deficiency of  insulin secretion and/or action. Diabetes 
produces long term damage, dysfunction and failure of various organs 
especially the eyes, renal,nerves,and cardiac and blood vessels.it is 
appropriately described as METABOLIC AND VASCULAR 
DISORDER. 
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DIAGNOSTIC CRITERIA: 
 
       Fasting plasma glucose>/=126mg/dl(7mmol),2hour glucose after 
oral glucose challenge>/=200 mg/dl(11.1mmol) or HbA1c>/=6.5%, 
random plasma glucose >/=200mg/dl accompanied by classic 
symptoms of DM warrants the diagnosis of DM
3
. 
            DIABETES RELATED COMPLICATIONS: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Micro-vascular complications: 
ocular disease 
        Retinopathy(non proliferative and proliferative) 
        Macular edema 
Neuropathy 
        Sensory and motor(mono & polyneuropathy) 
        Autonomic 
Nephropathy 
Macro-vascular complications 
Ischemic  heart disease 
Peripheral vascular disease 
Stroke  
Others 
Gastrointestinal( gastroparesis ,diarrhea) 
Genitourinary (uropathy,sexual dysfunction) 
Dermatologic,  cheiroarthropathy 
Infectious, periodontal disease 
Cataract, glaucoma ,hard of hearing 
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RISK FACTORS FOR STROKE : 
 
1. Gender : 
    Male gender increases the risk for stroke
4
. Men has 1.3 
times higher risk for stroke than female except in the highest ages. 
Difference in the risk between the gender disappears at high age 
over 80-85 years. The gender risk is different for subarachnoid 
haemorrhage where the risk is higher for women. 
2. Age:  
          Incidence of stroke increases with age in both men and 
women
5
. This increased stroke incidence is seen in ischaemic as 
well as for intracerebral haemorrhage, subarachnoid haemorrhage. 
The risk of stroke more than doubles with each decade of 
increased age after 55 years of age. 
3. Ethnicity: 
          African origin people have higher risk than Caucasians. 
This can be explained by the poor management of treatable risk 
factors. The proportion of intracerebral haemorrhage is higher in 
Chinese than Caucasians. In ischaemic stroke, the prevalence of 
intracranial artery stenosis is more frequent in East Asians and 
African Americans than in Caucasians
6
. 
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4. Genetic causes:   
         cerebral autosomal dominant arteriopathy with subcortical 
infarcts and leucoencephalopathy (CADASIL-notch-3gene), 
cerebral autosomal recessive arteriopathy and 
leucoencephalopathy (CARASIL-HTRA gene), MELAS 
(mitochondrial myopathy,encephalopathy,lactic acidosis, and 
stroke like episodes), homocystinuria, Fabry disease(alpha 
galactosidase gene), Ehlers–Danlos syndrome type IV,Marfan 
syndrome, pseudoxanthoma elasticum, HANAC 
(hereditaryangiopathy, nephropathy, aneurysm, and muscle 
cramps syndrome;COL4A1 mutation)
7
. All these above mentioned 
syndrome has stroke or stroke like episode as one of the feature of 
the different clinical manifestation. Sickle cell anemia increases 
the incidence of stroke in childhood
8
. Increased transcranial 
ultrasound velocities of the middle cerebral artery has increased 
risk in sickle cell anemic children. Single nucleotide 
polymorphism in the chromosome 9p21 associated with ischaemic 
stroke
9
, single nucleotide polymorphism in HDAC9 on 
chromosome 7p21.1 also associated with ischaemic stroke
10
. The 
APOE epsilon2&4 are related lobar intracerebral haenorrhage
11
. 
5. Diabetes mellitus:  diabetes mellitus has a deteriorating effect on 
arterial   blood vessels and it is a risk factor for ischemic stroke. 
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DM increases the incidence of recurrent stroke
12
. Lacunar infarcts 
may be more common in diabetic patients
13
. 
 
6. Hypertension: 
 
          It is the treatable risk factor for stroke. Hypertension is 
commonly detected in stroke patients with age less than 55 years 
of age. Both systolic and diastolic  BP is of importance as risk 
factor
14
. A systolic BP increase of 20 mmHg or a  diastolic BP 
increase of 10 mmHg more than doubles the risk of stroke death.  
Previous stroke/ Transient ischaemic attack: 
       Previous stroke is a powerful risk factor for new stroke. Also 
TIA increases  the risk of subsequent risk of stroke in short and 
long term. Higher risk among those with diabetes,age>60 
years,longer duration of TIA, TIA with  weakness  or speech 
disturbance
15
. 
7. White matter disease: 
      Both periventricular and subcortical white matter 
hyperintensities also increase the risk of subsequent stroke, 
independently of the presence of silent brain infarcts
16
. 
8. Dyslipidemia: 
     Increased cholesterol levels are associated with carotid artery 
atherosclerosis and so increases the risk of cerebral infarcts caused 
by large vessel disease
17
. on the other hand low cholesterol level 
28 
 
increases the risk of ICH
18
. Intense lowering of cholesterol level 
in stroke patients slightly increases the chance of ICH. 
9. Coagulation disorders: Antiphospholipid antibody and lupus 
anticoagulant have been associated with ischaemic stroke. A 
coagulation disorder causing a venous thrombosis may give rise to 
paradoxical embolism through patent foramen ovale. 
 
10.  Obstructive sleep apnea:  
     obstructive sleep apnea may increase BP and cause obesity. 
Obstructive sleep apnea itself is an independent risk factor for 
stroke
19
. Possible mechanisms include hypercoagulability, 
atherosclerosis, decreased cerebral blood flow. Wake up stroke 
recently been linked to obstructive sleep apnea
20
. 
11.  Renal disease: Renal increases the risk of  stroke in individuals 
with known atherothrombotic disease. Microalbuminuria has been 
independently associated with stroke. 
12.  Atrial fibrillation, cardiomyopathies, patent foramen ovale, 
valvular heart disease increases the risk of stroke. 
13.  Life style risk factors: 
a.  Smoking: cigarette smoking increases the risk for ischaemic 
stroke also increases the risk for ICH
21
. Both passive and active 
smoking increases the risk. Individuals who stop their smoking 
reduce their risk of stroke by upto 50%. 
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b. Alcohol : Excessive alcohol increase the stroke risk. Individuals 
who do not use any alcohol may have a slightly increased stroke. 
It is possible that temporary heavy alcohol consumption increases 
the risk of immediate stroke
22
. 
c. Diet: Fruit and vegetables may have a protective effect against 
both ischaemic and haemorrhagic stroke. Individuals eating three 
to five servings per day had a relative risk of stroke of 0.89 
compared with those consuming less fruit and vegetables
23
. Fish 
consumption also reduces the risk of stroke. 
d. Physical activity: Physical activity decreases the risk of stroke 
compared with no physical activity
24
. Daily exercise of at least 30 
minutes decreases the relative risk of stroke to between 0.69 and 
0.74.Physical activity of at least 30 minutes three to five times per 
week has been recommended. 
e. Obesity: body mass index of  25kg/m2 or more in men,30kg/m2 
or more in women increases the risk of ischaemic stroke
25
. waist : 
hip ratio also has been related to increased stroke risk. 
f. Hormonal therapy/OCP: OCP increases the risk of ischaemic 
stroke
26
; hormone replacement therapy has also been related to 
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increased risk of stroke. Active tamoxifen therapy increases the 
stroke risk. 
g.  Stress: self perceived psychological stress increases the stroke 
risk
27
. Both negative emotions and anger seem to be more 
common during the last 2 hours before stroke onset than during 
the preceding day or year. 
h. Socio economic factors: low socioeconomic status is associated 
with increased risk of stroke
28
. Neurological deficit is more severe 
in low socioeconomic and mortality ratio is high in low socio 
economic status. 
 
    Risk factors of ICH:  hypertension, diabetes, higher age, 
amyloid angiopathy, lower cholesterol, frequent alcohol use, 
patients using antiplatelets and anticoagulant medication. Cerebral 
microbleeds are more common in ICH than in ischaemic 
stroke/TIA. 
 
Risk factors for subarachnoid haemorrhage:   smoking, 
hypertension, female gender, increased age, alcohol consumption, 
ocp, genetic factors. 
 
Risk factors for cerebral venous thrombosis:  genetic or acquired, 
thrombophilia, haematological conditions including 
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polycythemia,thrombocythemia,anemia, and infection, 
dehydration. In female population  younger than 50 years of age 
with CVT have risk factors like oral contraceptives, pregnancy, 
puerperium. 
 
 
 
PATHOGENESIS : 
    Brain receives 55 mL to 70 mL of blood/100 g of brain/ min there by 
maintain its function normally. If the blood flow is less than 15 mL/100 
g/min, the resulting ischaemia with hypoxia, when sufficiently 
prolonged, may cause death of neurons and glia. The mean arterial 
blood pressure, resistance of cerebral vessel, local metabolic products 
(pH, PaO2, PaCO2),together with many known factors & unknown 
factors, help to maintain the blood flow. The blood flow varies in 
different areas of the brain and  autoregulation determines the regional 
flow to meet local metabolic needs. In regions of cerebral ischaemia, 
there is impaired self regulation and the microvasculature is 
unresponsive  to pressure changes, to vasoactive agents and to other 
forms of stimuli. Cerebral edema develops if there is vascular leak. To 
protect the brain from ischaemia, several collateral pathways exist. The 
four major extra-cranial arteries (carotid and vertebral arteries) form 
good-calibre, low-resistance anastomoses at the base of brain . The 
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post-Willisian anastomoses further protect the brain tissue from the 
effects of occlusion of single cortical branches . However, in the 
presence of generalised arterial disease or multiple skipped stenotic 
lesions (atherosclerosis), anomalous or congenital variations, these 
collateral pathways may prove inadequate and predispose to cerebral 
ischaemia resulting in brain infarction 
 
GENERAL CONSIDERATIONS : 
       If, for any reason, such a cardiac arrest or prolonged hypotension 
[systolic blood pressure (BP) falls below 70 mm Hg] occurs, brain 
tissue is significantly deprived of its nutrition for more than three 
minutes, ischaemic-hypoxic cerebral injury or infarction results. Such 
infarcts are either pale (ischaemic infarction in thrombosis) or may 
show petechial haemorrhages in the cortical mantle (haemorrhagic 
infarction in brain embolism). The sylvian region is commonly 
involved in middle cerebral artery occlusion (mid-field infarct) whereas 
with internal carotid artery lesions; the cerebral infarction is mostly 
located in the distal territory (end-field infarction). A mid-field infarct 
is produced by occlusion of a small penetrating vessel, and if located in 
the territory of major anatomical pathways, it may prove catastrophic. 
On the other hand, an endfield infarct resulting from occlusion of a 
major vessel in the neck with good collateral circulation may be 
asymptomatic. Obstruction to venous return can also result in 
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haemorrhagic infarction (e.g. cortical cerebral venous thrombosis). 
Acutely infarcted brain tissue is soft and swollen, frequently herniates 
downwards and may compress the vital centres within the brainstem, 
with fatal outcome. Like infarction elsewhere in the body, cerebral 
infarcts heal by gliosis leaving a firm scar or a cystic cavity. 
 
 
AETIOPATHOLOGY AND PATHOPHYSIOLOGY : 
    Cerebral infarction is usually attributed to partial or total occlusion of 
its regional microvasculature by thromboembolism. Cerebral atheroma 
is by far the most common underlying intimal vascular pathology, 
whereas thrombosis associated with arteritis (syphilitic, rheumatic, 
tuberculosis) is not an uncommon aetiology for ‘strokes in the young’ 
in India. If reperfusion established within 3 hours the ischemic 
penumbra zone can be salvaged. High cytosolic calcium, Na+/k+ 
ATPase failure , acidosis, free radicals and other unknown factors, are 
theimportant factors imapair the blood-brain barrier (BBB) and 
microvascular function . with  decreased ATP, there is delay in re-
synthesis of macromolecular proteins which is important for endothelial 
cell structure and function. Energy failures also induce proteolysis and 
lipolysis, production of arachidonic acid and platelet activating factors, 
cell adhesion molecules, nitric oxide and free radicals, post-ischaemic 
hypo-perfusion or hyperperfusion injuries resulting in further neuronal 
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impairment .Thus, development of cerebral infarct is not merely the 
result of ischaemia but the end-result of several highly complex 
‘ischaemia-modifying factors.’ For example, exposure of vascular 
endothelium to raised homocysteine (>100 μmol/L) levels leads to 
reduced nitric oxide, increased levels of adhesion molecules and 
expression of procoagulant factors like plasminogen activator inhibitor 
(PAI-1), tissue plasminogen activator (tPA), protein C (PC) and 
thrombomodulin (TM), which in turn promote platelet aggregation, 
leucocytes adhesion and thrombosis. 
CLINICAL FEATURES OF STROKE : 
 
Clinical Features 
      Obesity, feeble or absent peripheral arterial pulsations, vascular 
bruits, unequal or raised blood pressure, postural hypotension and 
retinopathy may be detected during general physical examination. In 
about 60% of the patients, prodromal warning symptoms of TIA may 
precede. Such episodes of TIA are usually brief (lasting for a few 
minutes to less than an hour) and may come singly or in successive 
spells over a number of hours or days or months, and leave no 
significant residual signs. TIAs may not be always related to posture or 
the level of BP, and may disappear altogether. However, in some cases 
(10% to 15%), an evolving or a full-blown stroke may follow the last 
ischaemic spell. When the stroke evolves in a stepwise manner, 
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(‘thrombosis in evolution’) the symptoms may appear in each limb in 
succession or simultaneously. This stuttering or intermittent 
progression is typical of atherothrombosis. Not infrequently, the stroke 
may announce itself abruptly as a single major catastrophic event 
(accomplished infarction or completed stroke). The other clinical 
manifestations depend on the site of arterial occlusion.  
 
INTERNAL CAROTID SYNDROME : 
     The cervical portion of the internal carotid artery near the carotid 
sinus is a common site for athero-stenosis  and about 60% of all 
thrombotic lesions are located here. Often, these lesions may be 
asymptomatic because of collateral anastomoses (external carotid-
ophthalmic anastomoses or from superficial and deep cervical 
anastomoses or from the opposite carotid artery through the anterior 
segment of the Circle of Willis). Warning symptoms precede a major 
ictus in nearly 50% of the subjects. Such symptoms include brief 
episodes of confusion, with speech difficulty (aphasia, dysarthria, 
dyslexia), sensory paraesthesia with or without motor weakness of the 
opposite side. Ipsilateral amaurosis fugax (transient monocular 
blindness), fleeting or semi-permanent, alternating with or accompanied 
by a contralateral hemiplegia or sensory deficit, is pathognomonic of 
carotid artery syndrome; however, these events occur in only 15% to 
20% of the patients. 
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The clinical manifestations of acute carotid artery occlusion are almost 
indistinguishable from those of middle cerebral syndrome. Feeble 
internal carotid or superficial temporal artery pulsations, dilated pupil 
and poorly pulsating retinal vessels on the side of the suspected carotid 
lesion and ocular or cervical bruits on the ipsilateral side may suggest 
the correct diagnosis. Carotid duplex Doppler sonography and 
angiography are helpful in defining the extent and degree of stenosis. In 
patients with an old or silent occlusive carotid artery lesion on one side, 
a new lesion on the opposite side may prove catastrophic. Here, the 
physical finding of bilateral hemiplegia (quadriplegia) with coma can 
be mistaken for basilar artery syndrome. 
 
ASYMPTOMATIC CERVICAL BRUIT : 
     A carotid bruit may be heard in the neck in about 5% of 
asymptomatic elderly patients (55 years to 80 years). Unless 
haemodynamically significant, it is very difficult to correlate the mere 
presence of a bruit with a subsequent TIA or stroke in that territory. 
The role of prophylactic endarterectomy to prevent a future stroke 
(estimated at 6% within next 3 years) has not been established by 
clinical trials. In such cases antiplatelet therapy may be prescribed.  
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MIDDLE CEREBRAL SYNDROME : 
     The cortical branches supply lateral surface of the cerebral 
hemisphere, except for the regions supplied by the anterior and 
posterior cerebral arteries. The areas of supply include the sensory-
motor cortex, the motor and sensory speech centres, auditory area and 
optic radiation. The penetrating branches (lenticulo-striate arteries) 
supply the putamen, globus pallidus, genu and posterior limb of the 
internal capsule. The clinical picture of middle cerebral artery occlusion 
is variable. Contralateral hemiplegia, hemianaesthesia with or without 
homonymous hemianopia and aphasia (dominant hemisphere) are 
common manifestations. Occlusion of the superior division presents as 
contralateral hemiparesis with sensory deficit and expressive aphasia 
(Broca’s aphasia), whereas Wernicke’s aphasia (sensory aphasia) is 
frequent with lesions of the inferior division of dominant side. 
Monoplegic symptoms with lesion of single cortical branches are not 
uncommon. Occlusion of penetrating branches (lenticulo-striate 
arteries) has been repeatedly blamed for a dense sensorimotor 
hemiplegic syndrome (‘capsular-hemiplegia’), but significant sensory 
loss seldom occurs with such a lesion and ‘pure motor hemiplegia’ is 
common. 
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ANTERIOR CHOROIDAL SYNDROME : 
     This artery supplies the posterior limb of the internal capsule, which 
carries the corticospinal and sensory fibres for the contralateral limb. 
This syndrome, which represents a true ‘capsular-hemiplegia’ (dense 
hemiplegia, hemianaesthesia and homonymous hemianopia), is rare. 
ANTERIOR CEREBRAL SYNDROME : 
     The cortical branches mainly supply the medial superior surface of 
the frontal lobe and the parietal lobe up to the paracentral lobule. The 
penetrating branches supply the anterior limb of the internal capsule 
and part of the head of caudate nucleus. 
An anterior cerebral artery occlusion proximal to the anterior 
communicating artery, in subjects with a symmetrical Circle of Willis, 
is frequently asymptomatic. Occlusion, distal to the anterior 
communicating artery, manifests itself by a sensorimotor paralysis of 
the opposite lower extremity with mild weakness of the opposite 
shoulder. Mental changes, ictal and urinary incontinence, gait 
disturbances, apraxia, grasp and sucking reflexes may accompany the 
above findings.Occlusion of an unpaired anterior cerebral artery 
(supplying both the hemispheres) results in a cortical type of 
paraplegia, with sphincter incontinence and a mental state in which the 
patient is alert but mute (akinetic mutism). Aphasia and hemianopia are 
never seen. Occlusion of the penetrating branches and of the Heubner’s 
artery is frequently blamed for ataxic tremors of the contralateral limbs 
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(frontal ataxia). Apraxias, idiomotor dyspraxia of the limbs and gait 
may also be present. 
 
POSTERIOR CEREBRAL SYNDROME : 
     This artery supplies the medial and inferior aspects of the occipital 
and temporal lobes. Its branches also supply the midbrain, cerebral 
peduncle, most of the thalamic and subthalamicregions. Embolic 
occlusion of the posterior cerebral arteries is not uncommon. 
Contralateral homonymous hemianopia is a significant finding and this 
results from infarction of the primary visual area (calcarine cortex); the 
central vision is frequently spared, even in cases with bilateral disease 
(gun-barrel vision). Other manifestations of visual dysfunction include 
illusory or distorted vision, visual-object agnosia and various forms of 
dyslexia without dysgraphia. The pupillary reflexes are well preserved. 
Contralateral hemiplegia from lesion of the cerebral peduncle 
(peduncular hemiplegia) and thalamic syndrome (Dejerine-Roussy 
syndrome) may also be present. In the thalamic syndrome, there is 
varying degree of sensory loss to all modalities and spontaneous 
burning or agonising pains are frequent (analgia dolorosa). Memory 
loss (amnesia) suggests lesion of the medial temporal cortex. 
Contralateral involuntary choreoathetosis or ataxic tremors are rarely 
observed. 
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VERTEBRO-BASILAR SYNDROME : 
      After traversing through the bony vertebral canals both vertebral 
arteries unite intra-cranially to form the basilar trunk. Their short 
paramedian and long circumferential branches supply the entire 
brainstem, cerebellum and the vestibular apparatus. TIA manifest as 
episodes of vertigo, dizziness, diplopia, dysarthria, dysphasia, 
incoordination of gait and limbs and bilateral signs of sensorimotor 
deficit. 
 
 Occipital headaches may be present. Ipsilateral 3rd nerve palsy with 
contralateral hemiplegia (Weber’s syndrome) or with crossed cerebellar 
ataxia (Claude’s syndrome) is diagnostic of midbrain localisation. 
Homolateral paralysis of the 7th nerve with contralateral hemiplegia 
and hemianaesthesia (Millard-Gubler syndrome) is suggestive of a 
pontine lesion. Palatal paralysis and ataxia of limbs, with impairment of 
posterior column sensation on same side of the body accompanied by 
diminution of pain and thermal sense on the opposite limbs 
(Wallenberg’s syndrome) indicate lateral medullary infarction from a 
distal vertebral artery lesion. Quadriplegia with bilateral conjugate, 
lateral gaze palsy and ‘mute state’ with fully preserved consciousness 
has been described (‘locked-in syndrome’) in infarction of the basis 
pontis (sparing the tegmentum), from a mid-basilar occlusion. 
Occlusion of isolated cerebellar branches may produce dizziness, 
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nausea, vomiting, nystagmus and appendicular or truncal ataxia without 
sensorimotor deficit in any limb. Such a syndrome should be 
differentiated from cerebellar haemorrhage where emergency surgical 
decompression may prove life-saving. 
  AORTIC ARCH SYNDROME : 
     The intriguing clinical syndrome is characterised by diminution or 
absence of the arterial pulsations in the vessels of the arms and the 
neck; the seat of the disease, irrespective of its aetiology, being located 
near the origins of the great vessels arising from the aortic arch. Several 
aetiological factors like congenital anomalies, trauma with or without 
aneurysm, chronic dissecting aneurysm, mediastinal tumours, 
thrombophilia syphilitic aortitis and atheromatosis appear to be one of 
the causes of this syndrome, and that an arteritis of undetermined origin 
is responsible for a good number of female cases. Likewise, it has been 
a prevalent impression that nearly all the cases of aortic arch syndrome 
reported from India are a form of arteritis of rheumatic, syphilitic or 
undetermined origin. It has now been appreciated that the primary 
lesion in such cases, particularly in men may not always be an arteritis. 
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                         STROKE  MANAGEMENT  OUTLINE 
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CLINICAL FEATURES OF ICH : 
     The focal signs and symptoms accompanying ICH reflect the 
location of the haemorrhage and are indistinguishable from ischaemia 
occurring in the same vascular territory. Lobar haemorrhages frequently 
produce contralateral weakness or sensory loss, language disturbance, 
hemianopia or lesser field disorders, and parietal lobe signs. Their 
relationship to the cortex makes them more likely to be complicated by 
seizures. Seizure are more frequent in ICH, occurring in as many as a 
quarter of individuals, although they are also seen in about 5% of 
patients with ischaemia, particularly early after onset. Occasionally, 
very small haematomas present with symptoms indistinguishable from 
transient ischaemic attacks (TIAs). However, majority of ICHs cause 
complete stroke. Putaminal haemorrhages typically cause contralateral 
hemiparesis with variable degrees of sensory loss, ataxia and with 
larger haematomas, a homonymous hemianopia. Thalamic 
haemorrhages can result in contralateral sensory loss and weakness, 
while if they extend to or compress the superior midbrain, they may 
result in depressed signs. Pontine haemorrhages often result in reduced 
consciousness, pinpoint  pupils, bilateral weakness and pontine cranial 
nerve dysfunction, and may be severely disabling. Cerebellar 
haemorrhages are particularly important to identify clinically as they 
may require surgical intervention, which can be life-saving. The onset 
can be deceptive, with initial nonspecific brainstem symptoms (e.g. 
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vertigo or double vision), followed a few hours or even days later by 
progressive clinical features, including gait, trunk or limb ataxia, 
nystagmus, headache, vomiting and coma from brainstem compression. 
Hemiparesis will be rare. The clinical course of cerebellar haemorrhage 
can be difficult to predict at onset. An abrupt deterioration may occur 
after a period of clinical stability. Moderate degrees of quadrigeminal 
cisternal compression predicts poor outcome unless the haematoma is 
evacuated early in the course. Severe mass effect on the cistern carries a 
poor prognosis. 
MIDDLE CEREBRAL ARTERY INFARCT:   
 
     It can present as cortical or deep infarct or both. 
SUPERFICIAL MIDDLE CEREBRAL ARTERY INFARCTS: 
                 Left superficial middle cerebral artery infarct associated with 
language disturbance and right superficial middle cerebellar artery 
associated with neglect. 
LARGE MIDDLE CEREBRAL ARTERY INFARCT : 
         Large infarcts cover  occlusion of superficial branch of middle 
cerebral artery and deep branch of middle cerebral artery .They have an 
unfavourable prognosis  as there is large area of infarct and produce a 
detrimental neurological deficit , which includes loss of consciousness.  
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               Large left middle cerebral artery infarct  
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 ANTERIOR OR SUPERIOR DIVISIONS OF MIDDLE CEREBRAL 
ARTERY INFARCT: 
       It causes opposite side hemiparesis , loss of sensation in contralateral side, 
gaze preference towards the side of lesion. Left side infarcts produce aphasia, 
buccofacial apraxia. Right side infarcts produce neglect with anosognosia.  
 
The above picture : MRI axial flair shows left anterior branch of MCA infarct. 
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MIDDLE CEREBRAL ARTERY POSTERIOR OR INFERIOR DIVISION 
INFARCT: 
      It produces sensory loss ,hemianopia with no or mild motor involvement. In 
left hemispheric infarct fluent aphasia predominates. In right posterior branch 
infarct produce neglect, altered sensorium . 
 
              MRI axial flair : left posterior branch of MCA infarct 
 
CORTICAL BRANCH SYNDROME: 
         Orbitofrontal infarct produce a frontal syndrome. Left prefrontal 
infarcts produce transcortical aphasia, right prefrontal infarcts  produce 
motor neglect. 
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. 
       Central sulcus or rolandic artery territory infarcts produce opposite 
side motor weakness and opposite side sensory loss. 
 
                     Bilateral central sulcus infarct  
 
 
This above picture shows bilateral central sulcus infarct, which causes bilateral 
motor weakness and sensory disturbances. 
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   BILATERAL THALAMIC INFARCT : 
 
 
 When bilateral thalamus supplied by single artery that originates from p1 
segment occlusion. 
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POSTERIOR CEREBRAL ARTERY INFARCTS :  
           
      Visual field defects, including hemianopia are the main clinical findings of 
PCA infarcts. Headache, generally unilateral, is rather frequent .  
Rt pca territory 
infarct 
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left paramedian tegmentum 
infarct 
         
 
 Left paramedian pontine infarct. 
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Left PICA infarct 
 
                 
 
 
                       Left anterior cerebellar artery territory infarct. 
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THE OXFORDSHIRE COMMUNITY STROKE PROJECT (OCSP) 
CLASSIFICATION : 
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THE TOAST CLASSIFICATION OF ACUTE ISCHAEMIC STROKE : 
(TOAST- TRIAL OF ORG 10172 IN ACUTE STROKE TREATMENT) 
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STROKE TREATMENT GUIDELINES :  
ACUTE ISCHEMIC STROKE :  
       Includes Medical support, IV thrombolysis, endovascular 
revascularization, antithrombotic treatment, neuroprotection, stroke 
centers and rehabilitation. 
MEDICAL SUPPORT : 
            Blood pressure lowering in ischemic stroke is indicated if there 
is malignant hypertension, associated acute coronary disease. 
Antihypertension  to be used  if BP > 185/110 mmhg, or when 
thrombolytic therapy to be administered. Lowering the BP with a beta-1  
blocker is the first step to reduce cardiac work and maintain 
bloodpressure. Fever control with antipyretics and surface cooling. 
Serum glucose should be monitored kept at <180 mg/dl. The larger the 
size of infarct chance of developing cerebral edema is more and should 
be treated with iv mannitol. Prevetntive measures regarding infection , 
deep venous thrombosis should be taken. 
IV THROMBOLYSIS : 
INDICATION : 
1.  Definitive Clinical diagnosis of stroke. 
2. Onset of ypmtoms to the time of administration of drug </= 4.5 
hours. 
3. No evidence of haemorrhage on CT brain. 
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4. Age >/= 18 years 
5. Informed consent from patient or surrogate. 
CONTRAINDICATIONS : 
1. Sustained blood pressure > 185/110 mmhg despite treatment 
2. Previous episode of stroke within 3 months; head injury within 3 
months; previous episode of intracranial hemorrhage. 
3. Minor stroke symptoms or rapidly improving symptoms 
4. Platelet <100000;HCT<25%;glucose >400mg/dl 
5. GI bleeding in preceding 21 days 
6. Heparin use within 48 hours and prolonged PTT or elevated INR. 
7. Major surgery in preceding 14 days.  
8. Recent MI 
9. Coma or stupor 
ADMINISTRATION OF rtPA :  
 Iv rtPA 0.9 mg/kg (maximum dose of 90 mg) iv as 10% 0f total dose 
administered bolus, followed by remainder of total dose 
administered over 1 hour. 
 Frequent BP monitoring. 
 No other antithrombotic treatment for 24 hours. 
 Avoid urethral catheterization for 2 hours 
 If there is decline in neurological condition, stop the infusion and 
reimage the brain emergently, give cryoprecipitate if necessary. 
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ENDOVASCULAR REVASCULARIZATION : 
       PROACT 2 trial found benefit for intra arterial prourokinase in 
acute MCA occlusions upto the 6
th
 hour following onset of stroke. 
      Endovascular mechanical thrombectomy used as an alternative or 
adjunctive treatment of acute stroke in patients who are not eligible for 
or who have contraindications or who have failed thrombolytic therapy. 
ANTITHROMBOTIC TREATMENT : 
 According to IST and CAST trial aspirin use within 48 hours of 
symptoms reduced the stroke recurrence risk and mortality minimally. 
ANTICOAGULATION : 
 A recent meta-analysis os all forms of heparin found no benefit in 
acute ischemic stroke. 
REHABILITATION : 
 Early physical , occupational , speech therapy. Preventing the 
complications like pneumonia, urinary tract infection, deep venous 
thrombosis , bed sore. 
                TREATMENT OF INTRACEREBRAL HEMORRHAGE : 
       Any identified coagulopathy should be treated. Prothrombin 
complex concentrate, fresh frozen plasma can be used. When ICH is 
associated with thrombocytopenaia fresh platelet transfusion is 
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indicated. Adequate BP control. For cerebellar hemorrhages 
neurosurgeon should be consulted immediately regarding evacuation. 
Most cerebellar haematoma more tha 3 cm requires surgical evacuation. 
Less than 1cm surgical evacuation is unnecessary.1-3 cm requires 
careful observation. 
       PREVENTION : 
1. Adequate BP control in chronic hypertension 
2. Avoid excess alcohol intake. 
3. Discontinuing illicit drugs like cocine and amphetamines. 
4. In amyloid angiopathy avoid oral anticoagulants. Antiplatelets can 
be used if there is an indication. 
     STROKE SCALES:  
       Stroke scales are used to assess the severity of stroke at the time of 
admission, and predict the outcome. They can be either Clinico-metric 
scales or functional impairment scales or handicap scales. National 
institute of health stroke scale, Scandinavian stroke scale, Canadian 
neurological scale, European stroke scale, Mathew stroke scale, 
orgogozo stroke scale, hess and hunt scale, oxfordshire community 
stroke project classification(bamford) are used for acute assessment of 
stroke. Modified rankin stroke scale, Lawton IADL scale, berg balance 
scale, stroke specific quality of life measure(ss-qol) are functional 
assessment scales. Barthel index, glascow outcome scale, functional 
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independence measurement, health survey sf-36 & 12 are outcome 
assessment scales. An accurate and valid, reproducible stroke 
assessment scale with less interpersonal variability is essential to 
quantify the stroke severity. 
             Among these National institute of health stroke scale is the 
most commonly used acute stroke assessment scale and it is most 
popular among neurologist. Previous stroke trial results, which are the 
basis for stroke management are based on the initial NIH stroke 
scale.NIH stroke scale has less interpersonal variability,easy to 
assess,better reproducibility. 
NATIONAL INSTITUTE OF HEALTH STROKE SCALE : 
 
     NIH stroke scale is initially developed as a research tool, now it is 
widely used as acute stoke assessment and predict the outcome of acute 
stroke patients and determine appropriate treatment for acute stroke 
patients. The NIH stroke scale is the better predictor of the size of the 
lesion and so the better measurement of stroke severity. It is a 15 item 
neurologic assessment scale, ratings of each item are scored with 3 to 5 
grades with 0 being the normal.NIH stroke scale comprises of , 
1. Level of consciousness which has three parts. LOC 
responsiveness(score 0-3), LOC questionnaire (0-2),LOC command 
(0-2). 
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2. Horizontal eye movement / best gaze (0-2). 
3. Visual field test (0-3). 
4. Facial palsy (0-3). 
5. Motor arm right (0-4), motor arm left (0-4). 
6. Motor leg right (0-4), motor leg left (0-4). 
7. Ataxia limb (0-3). 
8. Sensory (0-2). 
9. Best language (0-3). 
10.  Dysarthria/ speech (0-2). 
11.  extinction and inattention (0-2). 
 
 
 
 
 
 
 
With minimum score being 0 (no stroke symptoms), maximum  
score is 42  
(severe stroke).  
NIH stroke scale total 
score 
Severity of stroke 
0 No stroke symptoms 
0-4 Minor stroke 
5-15 Moderate stroke 
16-20 Moderate to severe stroke 
21-42 Severe stroke 
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NIH STROKE SCALE USAGE : 
1. To assess the severity of stroke at presentation 
2. one of the assessment tool for eligibility for tPA 
3. strong predictor of outcome, (NIHSS less than 6 indicates better 
chances of good recovery,more than 16 indicates worst 
prognosis),provides substantial prognostic information regarding 30 
day mortality risk in acute stroke patients. 
4.able to predict the stroke location, volume of brain damaged. 
 
      The incidence and prevalence of stroke in adults with diabetes is 
high, the risk of death also higher than people of similar age without 
diabetes. It is about 30% of stroke patients are diabetics and 16% of 
diabetics have stroke. stroke severity, outcome, chances of recurrence 
of stroke are more for diabetic patients. Diabetic patients have more 
traditional risk factors than non diabetic patients
29
. So physical activity, 
low carbohydrate diet, low fat diet, careful monitoring of diabetes and 
hypertension, weight loss will reduce the severity of stroke, improve 
the outcome and quality of life and reduces the recurrence of stroke. 
Hyperglycemia on admission is an important predictor of outcome in 
diabetics and non diabetic patients. Complications like urinary 
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infection, pneumonia, seizures were more frequent in diabetic patients 
with stroke than non- diabetic patients with stroke. 
       Glucose insulin in ischemic stroke patients (GIST), stroke patients 
without past history of diabetes, had 21% diabetes, 37% of patients had 
IGT ,42% of patients had normal glucose values after 3 months of 
stroke
30
. According to a FINNISH study, diabetic patients have stroke 
mortality of 16% for men and stroke mortality of 33% for women. 
Nearly 50% of people with impaired glucose tolerance develop diabetes 
over the period of 10 years, but lifestyle changes like physical activity, 
diet, weight control can substantially reduce this progression. Early 
detection of diabetes and to control blood glucose and other risk factors 
are essential in stroke patient. Hyperglycemia during the acute phase of 
stroke worsens the outcome, probable mechanism is high lactate level 
in brain tissue reduces the salvage of the penumbral tissue. 
 
        Obesity increases the risk of type 2 diabetes mellitus. Type 2 
diabetes mellitus is the important risk factor for the development of 
cardiovascular events including stroke. Type 2 diabetes not only 
increases the incidence of stroke events, also influences the severity of 
stroke and its outcome. These increased incidence and severity is 
attributable  not only to hyperglycemia, but also to insulin resistance,  
inflammation and activation of coagulation cascade. Diabetic patients 
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who were on antihyperglycemic agents like insulin, metformin, 
sulfonylureas had less severe stroke than patients who are not on 
antihyperglycemic drugs
31
. Thiozolidinediones enhance recovery in 
stroke patients. In an animal study treatment with linagliptin prior to 
stroke increases the number of surviving neurons than glimepiride in 
diabetic mice. Treatment with linagliptin increases the GLP-1 level. 
Anti inflammatory, anti oxidant, anti apoptotic actions appear to 
contribute to the neuroprotective action. Treatment with linagliptin 
increases the bioavailability of glucose dependent insulinotrophic 
polypeptide, pituitary adenylate cyclase activating polypeptide, stromal 
cell derived factor 1a which promote synaptic plasticity,neurogenesis, 
neuronal differentiation and reduce the severity of stroke. Recent study 
shows addition of linagliptin to metformin reduces the risk of nonfatal 
stroke than addition of glimepiride. 
By using NIH stroke scale as a predictor for care disposition among 
acute stroke patients on admission could reduce the costly processes, 
unnecessary length of stay at hospital. Atherosclerosis is the most 
important risk factor for stroke patients. Diabetes mellitus accelerates 
the atheroma formation. CVA with high NIH stroke scale can possibly 
occur in patients without vascular risk factors most probably because of 
absence of collaterals in the brain and non response of brain 
haemodynamics. Smoking doubles the risk of ischaemic stroke and 
occurred in younger ages when compared to non smokers. 
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       Diabetic patients with stroke were younger than non-diabetic 
patients with stroke
32
. Younger age in diabetic patients with stroke can 
be explained by diabetes mellitus accelerate atheroma formation and 
hyperglycemia accelerate and aggravate brain ischaemia. Transient 
ischaemic attacks were more frequent among diabetic patients than 
non-diabetic patients.  
      According to Amr kamel et al levels of cholesterol , triglycerides 
were higher in diabetic patients with stroke
32
. It is more significant for 
triglycerides. Dysarthria was more common in diabetic patients with 
stroke. Lacunar stroke syndromes were more common in diabetic 
stroke patients than non-diabetic stroke patients. Diabetic stroke 
patients had significantly worse Canadian stroke scale and non 
significantly worse Barthel Activity of Daily Living than non-diabetic 
stroke patients. In CT-Brain sub cortical infarcts are more common than 
cortical infarct in stroke patients with diabetics. Regarding the sex 
distribution, there was no difference between the diabetic stroke 
patients and non diabetic stroke patients. This is because diabetes 
mellitus has same imact on cerebral blood  vessels in both sexes. 
Diabetes mellitus increases the permeability if blood vessel walls and 
causes microalbuminuria. Microalbuminuria is an independent risk 
factor for coronary artery disease, with the same mechanism diabetes 
mellitus may cause cerebrovascular disease. 
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 Dyslipidemia have been associated with cerebrovascular 
atherosclerosis. Hypertriglyceridemia ti the most common abnormality 
seen in diabetic patients. According to Arboix et al found that 
hyperlipidemia was independently associated with ischemic stroke in 
patients with diabetes. Fibrinolytic activity in blood is regulated mainly 
by plasma plasminogen activator inhibitor. Increased levels of plasma 
plasmingen activator inhibitor present in patients with diabetes mellitus, 
coronary heart disease and cerebrovascular disease. Triglyceride levels 
correlate with plasma plasminogen activator inhibitor.  
 
 Poor metabolic control accelerates the microvascular disease, but its 
role in macrovascular complication in non insulin dependent diabetes 
mellitus is still controversial. Hyperglycemia associated with 
atherogenic lipoprotein changes and also it is a pro-coagulant state. 
Hyperglycemia decrease prostacyclin formation and increases the 
chance of thrombosis formation. Hyperglycemia cause glycosylation of 
proteins in vessel wall. These above mentioned derangements leads to 
accelerated atherosclerosis and increase the risk of stroke. 
The influences of diabetes on various vascular lesions that cause brain 
ischemia  
1. atherosclerosis of large intracranial arteries. 
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2. intracranial atheromatous branch disease of macroscopically visible 
branches of the intracranial arteries. 
3. degenerative abnormalities such as lipohyalinosis and fibrinoid 
changes within penetrating artery branchs visble only microscopically 
 
All these three above said can lead to subcortical infarct in brain 
parenchyma, the predominant infarct in patients with diabetes mellitus. 
     Diabetes increases the severity of stroke. Barett-connor-Khaw stated 
that it is possible that predisposes not to stroke per se but more 
irreversible brain damage during ischemia. Horowitz et al found that 
lesion size in CT-Brain  and haemorrhagic transformation correlates 
with glucose level. Baird et al.  stated that persistent hyperglycemia on 
serial glucose monitoring is an independent  determinant of infarct 
expansion and worse clinical outcome. 
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MATERIALS AND METHODS : 
 
     This  study was conducted in tirunelveli medical college. Patients 
are selected from medical wards, after getting an oral consent , from 
july 2014 to july 2015. 
INCLUSION CRITERIA : 
      All acute stroke patients admitted in medical wards in tirunelveli 
medical college hospital. 
EXCLUSION CRITERIA : 
1. Residual stroke patients. 
2. Patients with other comorbidities like sepsis , trauma , acute cns 
infection , encephalopathy. 
A detailed history regarding the onset of symptoms and duration of 
symptoms, associated symptoms like seizures, loss of consciousness, 
headache, vomiting were asked. Detailed history regarding, motor 
weakness, sensory disturbances, cerebellar autonomic disturbances, 
cranial nerve were asked. History regarding the status of diabetes, if 
diabetic duration if diabetes and his medication details are asked. Vital 
signs were recorded. Patients were examined according to national 
institute of health stroke scale and they were classified as minor stroke 
symptoms, mild stroke, moderate stroke, severe stroke. Patients were 
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examined and scored according to the performance of all 11 items in 
the NIH stroke scale. 
METHODS OF SCORING NIH STROKE SCALE: 
1.a. Level of consciousness : scored according to whether the patient is 
awake spontaneously(score-0), or require mild stimulation (score-1), 
deep painful stimulation (score-2), or patient responses with only reflex 
motor or autonomic reflex / totally unresponsive (score-3). 
1.b. LOC questions : patients age not the date of birth,curret month 
were asked. If patient answers both questions correctly( score-0), one 
question correctly (score-1), answers neither questions correctly  
(score-2). 
1.c. LOC Commands : ask the patient to open and close the eyes and 
grip the hand to command. If the patient does both the commands 
(score-0), patient able to perform one command (score-1), not able to 
perform either (score-2). 
2. Best gaze (horizontal eye movement): assess the patient’s ability to 
follow a finger or pen side to side. If it is normal (score-0), partial gaze 
palsy/ patient can gaze to side of infarct but can’t go past midline 
(score-1), total gaze palsy/forced deviation/ when the gaze is fixed to 
one side that is not overcome by oculocephalic maneuver (score-2). 
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3. visual field : visual field is tested by confrontation method,if patient 
cannot speak use visual threat. If no visual loss (score-0), if partial 
hemianopia/quadrantanopia (score-1), if complete hemianopia    (score-
2), bilateral hemianopia or complete blindness in both eyes including 
cortical blindness(score---3). 
4. Facial palsy : ask the patient to raise eyebrows and show teeth. 
Normal symmetrical movements  in both sides (score-0), partial 
paralysis/ total or near total paralysis  of lower half of face(score-1), 
complete paralysis of one or both sides/absence of facial movements in 
both upper and lower half of face(score-2). 
5. Motor arm : ask the patient to lift the upper limb(each limb 
separately) with palm down at ninety degree and hold it for 10 seconds. 
If no drift for full 10 seconds score-0, able to lift the limb but drift 
occurs before 10 seconds, does not hit bed score-1, some effort against 
gravity/ limb drift down to bed score-2, no effort against gravity score-
3, no movement at all score-4. This item tested and scored separately 
for both the upper limbs. 
6.  Motor leg : ask the patient to hold the leg at thirty degree for 5 
seconds. If there is no drift score-0, drift occurs before 5 seconds and 
does not hit the bed score-1,leg falls down to the bed but there is effort 
against gravity score-2, no effort against gravity score-3,no movements 
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at all score-4. This item tested and scored separately for both lower 
limbs. 
7. Motor coordination/limb ataxia : these item tested with eyes open. 
Test for both sides. If the limb is paralysed score-0,if patient can not 
understand score-0 given. If ataxia absent score-0, if ataxia present in 
one limb score-1,if ataxia present in both the limbs score-2. 
8. Sensory : This item is scored according to the patient’s ability to 
sense the pinprick. Test the face, arm (not hands), legs. patient in coma 
automatically given a score of 2. If there is no sensory loss score -0, 
score-1 is given if there is mild to moderate sensory loss but patient 
being aware of the touch. Score-2 for severe or total sensory loss/ 
patient being not aware of touch in face, arm or legs. 
9. Best language : by these time patient’s comprehensive ability can be 
assessed by preceding test results. This item is scored by asking the 
patient, what is happening in the picture that is attached with the 
NIHSS scoring sheet. Score 3 given automatically for coma patients. 
Score 0 given if there is no aphasia. Score 1 is given if there is mild to 
moderate aphasia. There is obvious reduction of fluency and/ or 
comprehension but patient able to make a conversation about provided 
materials. Score 2 is given if there is severe aphasia. All 
communication is through fragmentary expression. Examiner can not 
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identify materials provided by patient’s response. Score 3 is given if 
there is global aphasia. 
       10. Dysarthria : This item is tested and scored by asking the patient to 
read or repeat the sentence from the attached sheet in NIHSS sheet. 
Score 0 is given for normal. Score 1 is given if there is mild to 
moderate dysarthria/ slurring present but can be understood with some 
difficulty. Score 2 is given if there is severe dysarthria/ speech is so 
slurred as to be unintelligible in the absence of or out of proportion to 
any dysphasia, or is mute/anarthric.  
11. Extinction and inattention / formerly neglect : this item measures 
both the visual and sensory integration. Hold the fingers on both sides 
in the upper or lower quadrants of the patient’s visual field and ask the 
patient which finger is wiggling right or left or both. To determine 
sensory perception of hemispheres- have the patient closed his eyes 
then touch his/her face, arm, leg alternating right/left/both sequence. 
Score them only if they can actually indicate which side is being 
touched. Score 0 is given if there is no abnormality. Score 1 is given if 
there is loss to either vision or sensory modality. Score 2 is given if 
both sensory and vision loss present/ does not recognize own hand or 
orients to only one side of face. 
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      Patient scored on the day of admission and classified into (1) no 
stroke symptoms if score 0, (2) minor stroke 0-4, (3) moderate stroke if 
score 5 to 15,    (4) moderate to severe stroke if score 16 to 20, (5) 
severe stroke if score 21   to 42. 
      Patient’s random blood sugar on admission, fasting and 
postprandial blood sugar on next day taken. RFT, sodium, potassium, 
urine acetone done. Ecg, CT-Brain on admission taken. 
     Fasting blood sugar tested after a overnight fasting of 8 hours with 
adequate hydration. For post  prandial  glucose testing blood drawn 
after 2 hours of  food intake.  Blood sugar estimated by TRINDER’S 
method. 
  
TRINDER’S METHOD :  
  Glucose estimation by this method is explained by Trinder in 1969. It 
has almost all the attributes of an ideal automated colorimetric glucose 
oxidase procedure. 
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PRINCIPLE : 
         In the presence of catalytic enzyme glucose oxidase, Glucose in 
sample is oxidized to yield gluconic acid and   hydrogen peroxide. The  
peroxidase enzyme catalyses the oxidative coupling of 4-
aminoantipyrine with Phenol to yield a colured quinoneimine complex.  
Quinoneimine complex absorbance proportional to the concentration of 
glucose in sample. 
 
                                                 Glucose oxidase 
         Glucose +O2 +H2O         Gluconic acid+ H2O2 
 
                       peroxidase 
           H2O2+Phenol+4-aminoantipyrine                                Quinoneimine     
           dye+2H20  
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   REAGENT COMPOSITION 
REAGENT 1: ENZYME REAGENT 
ACTIVE 
INGREDIENT 
CONCENTRATION 
Glucose oxidase   >/=20000 U/L 
Peroxidase  >/= 2000 U/L 
Phenol   10 mmol/L 
Phosphate buffer   200mmol/L 
 
Glucose standard 100mg/dl. 
               Specimen : to prevent the glycolysis serum to be separated as soon as    
                possible.  
                sodium fluoride to be added to the sample to inhibit glycolysis. 
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        ASSAY PROCEDURE (end point) : 
Pipette into 
test tube 
labeled as 
 
Blank 
 
Standard 
 
Test 
sample ---- -----  10 microL 
standard ---- 10 microL  ----- 
Enzyme 
reagent 
1.0 ml 1.0 ml  1.0 ml 
 
             CALCULATION : 
 
             Glucose=                                             
                               (mg/dl) 
 
             Normal values reference. 
             Fasting 65-110 mg/dl ; Postprandial 90-130 mg/dl. 
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  Observation    
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78 
 
 
OBSERVATION AND RESULTS :  
      In this study stroke incidence regarding  age given in the below 
chart. Maximum incidence in 51-60 years of age (30% of study 
population). Followed by 41-50 years (26% 0f study population), then 
61-70 years of age (20% of study population). 
 Age  Patients  Percentage  
<40 6 12% 
41-50 13 26% 
51-60 15 30% 
61-70 10 20% 
71-80 4 8% 
>81 2 4% 
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               STROKE INCIDENCE AND ITS  AGE  DISTRIBUTION   
 
 
 
 
 
stroke incidence in relation to sex in this 
study . 
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            STUDY DESIGN 
 
 
  
 
 
 
Study design  : stroke in  50% of  DM, stroke in 50% of NON-DM were 
taken in this study.severity of stroke in each of this population analysed. 
Stroke severity in impaired glucose tolerance patients analysed. 
STROKE SEVERITY IN DIABTIC vs NON-DIABETIC 
PATIENTS : 
     Among 25 diabetic patients Minor stroke occurred in 2 patients , 
moderate stroke occurred in 18 patients , moderate to severe stroke 
occurred in 1 patient , severe stroke occurred in 4 patients. Among non-
diabetic patients minor stroke occurred in 2 patients , moderate to 
severe stroke occurred in 22 patients , severe stroke occurred in 1 
patient. Stroke severity measured by NIH stroke scale. 
 
DM 25 
NON -
DM 
25 
DM 
50% 
Non-
DM 
50% 
study design 
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STROKE SEVERITY IN DM vs NON-DM PATIENTS BY NIH 
STROKE SCALE : 
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severity of stroke 
1-minor 
2-moderate 
3-moderate to severe 
4-severe 
stroke severity in DM vs NON-DM 
DM 
Non-DM 
  NIH_Stroke Scale 
  1 2 3 4 
DM 2 18 1 4 
Non-
DM 2 22 0 1 
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Mean score  of NIH stroke scale in diabetic patients is 12.56 and 
standard deviation is 11.13. Mean score of NIH stroke scale in non-
diabetic patients is 7.12 and standard deviation is 6.24 . By independent 
sample t test p value P < 0.038 . there is statistically significant 
difference in  stroke severity between diabetic stroke patients and non-
diabetic patients . 
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  Mean S.D 
P 
value  
DM 12.56 11.13 
0.038 
Non-
DM 7.12 6.24 
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COMPARING NIHSS AND THEIR BLOOD SUGAR VALUES 
 
                                         Independent sample t Test. 
 
 
 
 
 
  DM Non-DM   
  Mean S.D Mean S.D P value 
RBS 187.52 67.47 109.12 30.67 <0.0001 
FBS 168.8 26.37 94.32 20.84 <0.0001 
PPBS 231.4 36.47 136.2 28.51 <0.0001 
 Sodium 137.56 7.17 138.64 5.3 0.548 
NIH_Score 12.56 11.13 7.12 6.24 0.038 
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 The above chart shows the mean values of  RBS , FBS , PPBS levels in 
Diabetic and non-diabetic stroke patients. There is statistically 
significant correlation between severity of stroke in diabetic patients 
and their Random blood sugar and fasting blood sugar .  
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       PEARSON CORRELATION TEST : 
 
By Pearson correlation test there is statistically significant correlation  
between random blood sugar severity of stroke in diabetic patients. 
There is a linear relationship between random blood sugar and severity 
of stroke. Also there is statistically significant correlation between 
fasting blood sugar and severity of stroke in diabetic patients. There is 
linear relationship between FBS and severity of stroke in diabetic 
patients. No statistically significant correlation between postprandial 
blood sugar and stroke severity. 
 
 
 
 
Stroke Score 
  DM Non-DM 
  
Coefficient 
correlation p value  
Coefficient 
correlation 
p 
value  
RBS 0.592 0.002 0.169 0.419 
FBS 0.435 0.03 -0.05 0.813 
PPBS 0.27 0.192 -0.071 0.736 
Sodium -0.808 <0.0001 -0.588 0.002 
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STROKE SEVERITY IN IMPAIRED GLUCOSE TOLERANCE : 
 
 
 
 
 
Stroke patients with impaired glucose tolerance in this study had 
moderate stroke severity according to NIHSS in this study. 
 
         
 
 
 
 In this study twelve patients had impaired glucose tolerance. The 
above table shows the mean value of  the NIHSS severity score. There 
is no statistically significant difference between the IGT stroke patients 
and stroke patients with euglycemia. 
    NIH_Stroke Scale 
    1 2 3 4 
IGT 
Yes 0 12 0 0 
No 2 10 0 1 
 
IGT 
 
IGT  Mean S.D 
Yes 6.58 1.67 
No 7.61 8.64 
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The above chart shows the mean value of NIH stroke scale in impaired 
glucose tolerance patients. Mean  NIHSS in IGT is 6.58 ,Mean NIHSS 
in euglycemic is 7.61. No statistically significant increase in severity of 
stroke in Impaired glucose tolerance patients. 
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INCIDENCE OF SEVERE STROKE IN DM VS NON-DM PATIENTS : 
  
Severe 
Stroke   
  Yes No 
DM 4 21 
Non-DM 1 24 
     In this study five patients had severe stroke according to NIHSS( 
NIHSS > 21). Among them four patients are diabetic ,one patient is 
non-diabetic. So there is evidence of severe stroke incidence in 
diabetics are more than non-diabetic patients. 
 
SEVERE STROKE AND HYPONATREMIA : 
        
 
    
Severe 
Stroke   
P value  
  
 
    Yes No 
Fisher's 
exact test 
 
Sodium 
<130 
Yes 4 1 
<0.0001 
  
 
No 1 4 
   
Among five severe stroke patients, four patients had decreased sodium. 
There is statistically significant stroke severity in hyponatremia. 
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DISCUSSION 
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DISCUSSION : 
        
         Stroke is the important cause of mortality and morbidity in 
worldwide. Risk factors for stroke are increased age , male , systemic 
hypertension, Diabetes mellitus, Dyslipidemia , Renal and cardiac 
disease , smoking , alcoholics , obesity , physical inactivity. Most of the 
existing studies regarding severity of stroke in diabetics were conducted 
in developed countries and large cities of developing countries like 
india. This study has been conducted predominantly in rural population 
in and around Tirunelveli. 
           In our study stroke incidence is more common in male patients 
than female patients. Incidence  of stroke in male patiets are 66% and 
incidence of stroke in female patients are 34%. Most common age 
groups are 51-60 years (30%) , 41-50 years (26%), 61-70 years (20%). 
According to R P Eaten et al , the stroke incidence was more common 
in males. Most common age groups are 51-60 rears of age. 
         In our study the severity of stroke is more in diabetic patients .  
There is linear relationship between Random blood sugar on admission 
and severity of stroke . similar results found in Ahmed Hussein et al 
,hyperglycemia level at the time of admission influences the severity of 
stroke
33
. In our study high Random blood sugar level taken at the time 
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of admission high NIH stroke scale score found in  diabetic stroke 
patints (P < 0.02). Also there is linear relationship between fasting 
bloodsugar and NIH stroke scale score (P < 0.03). According to Clara 
Hjalmarsson et al , poor glycemic control prior to ischaemic stroke is an 
independent risk factor for poor survival ,and a marker for stroke 
severity (high NIHSS on admission) and associated with poor 
outcome
34
. 
          According to Copenhagen stroke study , Henrik stig jogensen et 
al , diabetic stroke patients are younger than non-diabetic stroke 
patients
35
. They had hypertension more frequently. Occurrence of 
intracerebral haemorrhage as the cause of stroke in diabetic patients is 
less common . In our study among 50 patients , four patients had 
intracerebral haemorrhage. Among 25 diabetic patients only 2 patients 
had intracerebral haemorrhage , 23 patients had ischaemic stroke. This 
study also shows the incidence of intracerebral haemorrhage as the 
cause of stroke is less common. 
        K Ghanachandra Singh et al , the incidence of stroke is more 
common in the age group of 51-60 years which is in agreement with 
our study
36
. Higher mortality with stress hyperglycemics and diabetics.  
Recovery  of ATP generation impaired in stroke patients with 
hyperglycemia is impaired. It was stated there is increased adhesiveness 
of red blood cells  in diabetic stroke patients.  
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     According to Karl Matz et al , patients with diabetes had more 
severe stroke attacks  when compared to non-diabetic stroke patients , 
impaired glucose tolerance patients and transient hyperglycemic 
patients
30
. Higher rate of infectious complications and worse outcome 
in diabetic stroke patients. In our study also shows occurrence of more 
severe stroke in diabetic patients. But in our study there is no 
statistically significant severity of stroke in impaired glucose tolerance. 
                According to Amr Kamel et al , diabetic patients were 
younger than non-diabetic stroke patients
32
. Stroke patients with 
diabetes had worse Canadian stroke scale. In our study stroke patients 
with diabetics had severe/worse NIH stroke scale. According to Amr 
Kamel et al diabetic stroke patients had high number of lacunar stroke. 
       According to the study by  Sheikh saleem et al, out of 1000 stroke 
patients 353 had hyponatremia. Their mortality rate when compared to 
patients with normal sodium level were high and statistically 
significant. In our study among five severe stroke patients 4 patints had 
hyponatremia. it is in agreement with the above study that 
hyponatremia influences the severity of stroke. 
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       SUMMARY 
            AND     
       CONCLUSION 
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 SUMMARY & CONCLUSION : 
In our study it was found , 
 Males were more commonly affected than females. 
 Age group 51-60 years more commonly affected. 
 Diabetic patients had more severe stroke than non-diabetic patients. 
 Random blood sugar on admission had linear relationship with NIH   
  stroke  scale in diabetic patients. 
 Fasting blood sugar also had linear relationship with NIH stroke   
     scale in  diabetic patients.    
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 Annexure 1 
       
Clinical proforma 
Personal details 
                 NAME :                                             AGE:           SEX: 
             OCCUPATION: 
             ADDRESS:  
CHIEF COMPLAINTS: 
 
HISTORY OF PRESENT ILLNESS: 
 
PAST HISTORY: 
 
FAMILY HISTORY: 
 
GENERAL EXAMINATION: 
 
VITAL SIGNS: 
 
CLINICAL EXAMINATION: 
 
NIH STROKE SCALE
Patient Identification.              -                    -                 
Pt. Date of Birth              /             /          
Hospital                                                 (           -           ) 
Date of Exam              /             /          
Rev 10/1/2003 
 
 
 
               Person Administering Scale    
 
Administer stroke scale items in the order listed.  Record performance in each category after each 
subscale exam.  Do not go back and change scores.  Follow directions provided for each exam 
technique.  Scores should reflect what the patient does, not what the clinician thinks the patient can 
do.  The clinician should record answers while administering the exam and work quickly. Except 
where indicated, the patient should not be coached (i.e., repeated requests to patient to make a 
special effort). 
 
 
1a.   Level of Consciousness: The investigator must 
choose a response if a full evaluation is prevented by 
such obstacles as an endotracheal tube, language 
barrier, orotracheal trauma/bandages.  A 
3 is scored only if the patient makes no movement (other 
than reflexive posturing) in response to noxious 
stimulation. 
0 =   Alert; keenly responsive. 
1 =   Not alert; but arousable by minor 
stimulation to obey, answer, or respond. 
2 =   Not alert; requires repeated stimulation to 
attend, or is obtunded and requires strong or 
painful stimulation to make movements (not 
stereotyped). 
3 =   Responds only with reflex motor or autonomic 
effects or totally unresponsive, flaccid, and 
areflexic. 
 
 
 
 
 
 
 
 
1b.  LOC Questions:  The patient is asked the month 
and his/her age. The answer must be correct - there is 
no partial credit for being close. Aphasic and stuporous 
patients who do not comprehend the questions will score 
2.   Patients unable to speak because of endotracheal 
intubation, orotracheal trauma, severe dysarthria from 
any cause, language barrier, or any other problem not 
secondary to aphasia are given a 1.  It is important that 
only the initial answer be graded and that the examiner 
not "help" the patient with verbal or non-verbal cues. 
 
0 =    Answers both questions correctly. 
1 =    Answers one question correctly. 
 
2 =    Answers neither question correctly. 
 
 
1c.   LOC Commands:  The patient is asked to open 
and close the eyes and then to grip and release the 
non-paretic hand.   Substitute another one step 
command if the hands cannot be used.   Credit is given 
if an unequivocal attempt is made but not completed 
due to weakness.   If the patient does not respond to 
command, the task should be demonstrated to him or 
her (pantomime), and the result scored  (i.e.,  follows  
none,  one  or  two  commands).    Patients  with trauma, 
amputation, or other physical impediments should be 
given suitable one-step commands. Only the first attempt 
is scored. 
 
0 = Performs both tasks correctly. 
1 = Performs one task correctly. 
2 = Performs neither task correctly. 
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2.   Best Gaze:   Only horizontal eye movements will 
be tested. Voluntary or reflexive (oculocephalic) eye 
movements will be scored, but  caloric  testing  is  not  
done.    If  the  patient  has  a  conjugate deviation of 
the eyes that can be overcome by voluntary or reflexive 
activity, the score will be 1.   If a patient has an 
isolated peripheral nerve paresis   (CN III, IV or VI), 
score a 1.  Gaze is testable in all aphasic patients. 
Patients with ocular trauma, bandages, pre-existing 
blindness, or other disorder of visual acuity or fields 
should be tested with reflexive movements, and a 
choice made by the investigator. Establishing eye 
contact and then moving about the patient from side to 
side will occasionally clarify the presence of a partial 
gaze palsy. 
 
0 = Normal. 
1 = Partial gaze palsy; gaze is abnormal in one 
or both eyes, but forced deviation or total gaze 
paresis is not present. 
2 = Forced deviation, or total gaze paresis not 
overcome by the oculocephalic maneuver. 
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3.  Visual:  Visual fields (upper and lower quadrants) are 
tested by confrontation, using finger counting or visual 
threat, as appropriate. Patients may be  encouraged, but  
if  they look  at  the  side  of  the moving fingers 
appropriately, this can be scored as normal. If there is 
unilateral blindness or enucleation, visual fields in the 
remaining eye are scored.   Score 1 only if a clear-cut 
asymmetry, including quadrantanopia, is found.  If patient 
is blind from any cause, score 3. Double simultaneous 
stimulation is performed at this point.  If there is extinction, 
patient receives a 1, and the results are used to respond to 
item 11. 
 
0 = No visual loss. 
1 = Partial hemianopia. 
   2 = Complete hemianopia. 
    3 = Bilateral hemianopia (blind including cortical 
blindness). 
 
 
4.  Facial Palsy:  Ask – or use pantomime to encourage – 
the patient to show teeth or raise eyebrows and close 
eyes.  Score symmetry of grimace in response to 
noxious stimuli in the poorly responsive or non-
comprehending patient.   If facial trauma/bandages, 
orotracheal tube, tape or other physical barriers obscure 
the face, these should be removed to the extent possible. 
0 = Normal symmetrical movements. 
1 = Minor paralysis (flattened nasolabial fold, 
asymmetry on smiling). 
2 = Partial paralysis (total or near-total paralysis of 
lowerface). 
3 = Complete paralysis  
 
 
 
 
 
 
 
5.  Motor Arm:  The limb is placed in the appropriate 
position: extend the  arms  (palms  down)  90  degrees  (if  
sitting)  or  45  degrees  (if supine).   Drift is scored if the 
arm falls before 10 seconds.   The aphasic patient is 
encouraged using urgency in the voice and pantomime, 
but not noxious stimulation.  Each limb is tested in turn, 
beginning with the non-paretic arm. Only in the case of 
amputation or joint fusion at the shoulder, the examiner 
should record the score as untestable (UN), and clearly 
write the explanation for this choice. 
0 = No drift; limb holds 90 (or 45) degrees for full 10 
seconds. 
1 = Drift; limb holds 90 (or 45) degrees, but drifts 
down before full 10 seconds; does not hit bed or 
other support. 
2 = Some effort against gravity; limb cannot get to 
or maintain (if cued) 90 (or 45) degrees, drifts down 
to bed, but has some effort against gravity. 
3 = No effort against gravity; limb falls. 
4 = No movement. 
UN = Amputation or joint fusion,                                              
 5a. Left Arm 
 5b. Right Arm 
 
 
6.  Motor Leg:  The limb is placed in the appropriate 
position:  hold the leg at 30 degrees (always tested 
supine).  Drift is scored if the leg falls before 5 seconds.   
The aphasic patient is encouraged using urgency in the 
voice and pantomime, but not noxious stimulation. 
Each limb is tested in turn, beginning with the non-
paretic leg.  Only in the case of amputation or joint 
fusion at the hip, the examiner should record the score 
as untestable (UN), and clearly write the explanation for 
this choice. 
0 = No drift; leg holds 30-degree position for full 5 
seconds. 
1 = Drift; leg falls by the end of the 5-second period 
but does not hit bed. 
2 = Some effort against gravity; leg falls to bed by 
5seconds, but has some effort agains tgravity. 
3 = No effort against gravity; leg falls to bed 
immediately         
 4 = No movement .UN = Amputation or joint fusion 
6a. Left Leg 
 6b. Right Leg 
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   7. Limb Ataxia: This item is aimed at finding evidence of 
a unilateral cerebellar lesion.   Test with eyes open.   In 
case of visual defect, ensure testing is done in intact 
visual field.   The finger-nose-finger and heel-shin tests 
are performed on both sides, and ataxia is scored only if 
present out of proportion to weakness.  Ataxia is absent in 
the patient who cannot understand or is paralyzed.  Only 
in the case of amputation or joint fusion, the examiner 
should record the score as untestable (UN), and clearly 
write the explanation for this choice.  In case  of  
blindness,  test  by  having  the  patient  touch  nose  from 
extended arm position. 
0 = Absent. 
1 = Present in one limb. 
2 = Present in two limbs. 
UN = Amputation or joint fusion,  
 
 
8.    Sensory:    Sensation or  grimace  to  pinprick  when  
tested,  or withdrawal from noxious stimulus in the 
obtunded or aphasic patient. Only sensory loss attributed 
to stroke is scored as abnormal and the examiner should 
test as many body areas (arms [not hands], legs, trunk, 
face) as needed to accurately check for hemisensory loss.  
A score of 2, “severe or total sensory loss,” should only be 
given when a  severe or  total loss  of  sensation can  be 
clearly demonstrated. Stuporous and aphasic patients will, 
therefore, probably score 1 or 0. The patient with 
brainstem stroke who has bilateral loss of sensation is 
scored 2.  If the patient does not respond and is 
quadriplegic, score2.  Patients in a coma (item 1a=3) are 
automatically given a 2 on thisitem. 
0 = Normal; no sensory loss. 
1 = Mild-to-moderate sensory loss; patient feels 
pinprick is less sharp or is dull on the affected side; 
or there is a loss of superficial pain with pinprick, 
but patient is aware of being touched. 
2 = Severe to total sensory loss; patient is not 
aware of being touched in the face, arm, and leg. 
 
 
9. Best Language: A great deal of information about 
comprehension will be obtained during the preceding 
sections of the examination. For this scale item, the 
patient is asked to describe what is happening in the 
attached picture, to name the items on the attached 
naming sheet   and   to   read   from   the   attached   list   
of   sentences. Comprehension is judged from responses 
here, as well as to all of the commands in the preceding 
general neurological exam.  If visual loss interferes with 
the tests, ask the patient to identify objects placed in the 
hand, repeat, and produce speech.   The intubated patient 
should be asked to write. The patient in a coma (item 
1a=3) will automatically score 3 on this item.   The 
examiner must choose a score for the patient with stupor 
or limited cooperation, but a score of3 should be used only 
if the patient is mute and follows no one-step commands. 
0 = No aphasia; normal. 
1 = Mild-to-moderate aphasia; some obvious 
loss of fluency or facility of comprehension, 
without significant limitation on ideas expressed or 
form of expression. Reduction of speech and/or 
comprehension, however, makes conversation 
about provided materials difficult or impossible. 
For example, in conversation about provided 
materials, examiner can identify picture or naming 
card content from patient’s response 
.2 = Severe aphasia; all communication is through 
fragmentary expression; great need for inference, 
questioning, and guessing by the listener. Range 
of information that can be exchanged is limited; 
listener carries burden of communication. 
Examiner cannot identify materials provided from 
patient response. 
3 = Mute, global aphasia; no usable speech or 
auditory comprehension. 
 
 
10.    Dysarthria: If  patient is  thought to  be  normal, an  
adequate sample of speech must be obtained by 
asking patient to read or repeat  words  from  the  
attached  list.    If  the  patient  has  severe aphasia, the 
clarity of articulation of spontaneous speech can be 
rated.  Only if the patient is intubated or has other physical 
barriers to producing  speech,  the   examiner  should  
record  the   score   as untestable (UN), and clearly write 
an explanation for this choice.  Do not tell the patient why 
he or she is being tested. 
0 = Normal. 
1 = Mild-to-moderate dysarthria; patient slurs at 
least some words and, at worst, can be understood 
with some difficult 
.2 = Severe dysarthria; patient's speech is so 
slurred as to beunintelligible in the absence of or 
out of proportion to any dysphasia, or is 
mute/anarthric 
.UN = Intubated or other physical barrier, 
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11.   Extinction and Inattention (formerly Neglect):   
Sufficient information  to  identify  neglect  may  be  
obtained  during  the  prior testing.   If the patient has a 
severe visual loss preventing visual double 
simultaneous stimulation, and the cutaneous stimuli 
are normal, the score is normal.   If the patient has 
aphasia but does appear to attend to both sides, the 
score is normal.  The presence of visual spatial neglect 
or anosagnosia may also be taken as evidence of 
abnormality.  Since the abnormality is scored only if 
present, the item is never untestable. 
  
0 = No abnormality 
1 = Visual, tactile, auditory, spatial, or personal 
inattention 
or extinction to bilateral simultaneous 
stimulation in one of the sensory modalities. 
 
2 = Profound hemi-inattention or extinction 
to more than one modality; does not 
recognize own hand or orients to only one 
side of space. 
 
s.no ip no name age sex
DM-
1,NON 
DM-2
impaired 
glucose 
tolerance 
IGT-1,non  
IGT-2
Random 
blood 
sugar
urea creatinine  sodium potassium fbs ppbs
urine 
acetone
hb(gm%) platelet ecg ct brain nihss
level of 
conscioun
ess
LOC 
QUESTIO
NS
LOC 
COMMA
NDS
BEST 
GAZE
VISUAL
FACIAL 
PALSY
MOTOR 
ARM-L
MOTOR 
ARM-R
MOTOR 
LEG-L
MOTOR 
 LEG R
LIMB 
ATAXIA
SENSORY
BEST 
LANGUA
GE
DYSARTH
RIA
EXTINCTI
ON&INAT
TENTION
total 
score
1 46740 Alaganantham 52 M 1 159 26 0.6 140 4.2 149 364 negative 14.6 2.72 normal
rt 
capsulogangli
onic infarct
1 0 0 0 0 2 3 0 3 0 0 0 0 0 0 9
2 46778 Murugaiah 60 M 2 1 82 34 0.4 141 3.8 68 186 negative 16 1.39
coronary 
artery 
disease
Lt fronto 
parietal 
region 
haemorrhage
2 1 1 0 0 2 0 2 0 2 0 0 1 0 0 11
3 26852 LAKSHMANAN 67 M 1 204 39 1.2 138 4.1 165 234 negative 14 1.98 normal
Lt capsulo 
ganglionic 
infarct
1 1 1 0 0 2 0 3 0 3 0 0 1 0 0 12
4 45235 Ponnusamy 52 M 2 1 125 47 1 140 4.4 102 147 negative 16.1 2.36 normal
rt lateral 
medullary 
infarct
0 0 0 0 0 0 0 0 0 0 2 2 0 2 0 6
5 23810 Ammasi 42 M 1 241 39 1.3 124 4.2 181 284 negative 13.2 1.75 normal
Lt MCA 
territory 
infarct
3 2 2 1 3 3 4 4 4 4 0 2 3 2 2 39
6 42515 Rasathi 45 F 2 1 219 36 1.2 134 4.2 117 146 negative 11.5 2.34
atrial 
fibrillation
rt 
capsulogangli
onic infarct
0 0 0 0 0 2 3 0 3 0 0 0 0 0 0 8
7 43921 Kulanthaivelu 48 m 2 2 130 18 0.7 124 4 96 106 negative 10.6 1.75 normal
Lt MCA 
territory 
infarct
2 2 2 1 3 2 4 4 4 4 0 1 3 2 2 36
8 42270 Salim 55 M 1 425 33 2 123 4.5 245 273 negative 13.5 3.8
Lt 
ventricula
r 
hypertrop
hy,cad
multi infarct 2 2 2 1 3 2 4 4 4 4 0 1 3 2 2 36
9 42821 Paneer pandi 48 M 1 107 22 0.6 121 3.4 215 242 negative 14.6 2.73 CAD
intracerebral 
haemorrhage
-Lt
2 2 2 1 3 2 4 4 4 4 0 1 3 2 2 36
10 46775 ESAKKIAMMAL 77 f 2 2 89 20 0.9 147 3.8 105 114 negative 13.3 2.63 CAD
B/L thalamic 
infarct
1 1 0 0 0 0 0 0 0 0 0 1 1 1 1 6
11 46821
kuthalathamma
l
55 F 1 348 141 3.9 133 5.9 141 203 negative 13.1 5.05 LVH
Lt-capsulo 
ganglionic 
haemorrhage
2 2 2 1 3 2 4 4 4 4 0 1 3 2 2 36
12 48229 Rajan 68 M 2 2 121 66 1.2 150 4.4 123 104 negative 14.6 2.47 normal
Lt-thalamic 
bleed
0 0 0 0 0 2 1 0 1 0 0 1 0 0 0 5
13 40826 balakrishnan 46 M 2 2 107 23 0.9 139 4.2 112 75 negative 13.2 2.17 normal
infarct Lt-
corona 
radiata
0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 2
14 40824 karuppasamy 62 M 2 2 124 29 1.2 139 4.2 102 101 negative 14.1 1.98
incomplet
e RBBB
infarct Rt-
capsulogangli
onic region
0 0 0 0 0 2 1 0 1 0 0 0 0 0 0 4
15 37951 Muthulakshmi 68 F 1 181 51 1.2 146 4.6 161 242 negative 12.4 2.14 normal
Lt-capsulo 
ganglionic 
infarct
1 1 1 0 0 2 0 3 0 3 0 0 1 0 0 12
16 37981
vinayagatham
mal
79 F 2 2 121 18 1.9 139 4.1 82 138 negative 13.3 2.86 normal
posterior 
circulation 
stroke
0 0 0 1 1 0 1 1 1 1 1 0 0 0 1 8
17 41019 kulathuran 58 m 1 139 224 10.1 136 5.3 161 201 negative 9.7 1.74 LVH
Lt-capsulo 
ganglionic 
infarct
0 0 0 0 0 2 0 2 0 2 0 0 1 0 0 7
18 40827 Ramzan kani 35 M 1 157 18 0.7 141 4 121 202 negative 12 1.81 normal
Rt cerebellar 
infarct
0 0 0 0 0 0 0 0 0 0 2 0 0 1 0 3
19 40868 mariappan 40 M 1 143 40 1.4 139 4.2 162 204 negative 13.4 2.13 normal
Lt capsulo 
ganglionic 
infarct
0 0 0 0 0 2 0 2 0 2 0 0 1 0 0 7
20 43928 kumar 42 M 2 1 97 56 0.9 142 4 60 146 negative 17.4 3.2 normal
rt 
capsulogangli
onic infarct
0 0 0 0 0 2 2 0 2 0 0 0 0 0 0 6
21 46839 subramaniyan 60 m 2 1 83 16 1.2 137 4 74 150 negative 17.1 0.88 normal
Lt fronto 
temporal 
infarct
0 0 0 0 0 1 0 2 0 2 0 0 0 0 0 5
22 43925 syed ali fathima 87 F 1 151 59 2.4 127 4.1 142 204 negative 6 0.65 LVH
Lt fronto 
temporal 
infarct
2 2 2 0 1 1 0 3 0 3 0 0 1 1 1 17
23 39388 muthuvel 55 M 2 2 62 21 1 135 4.1 64 86 negative 12 1.83 normal
lt.capsulogan
glionic infarct
0 0 0 0 0 1 0 2 0 2 0 0 0 0 0 5
24 39359
panakottai 
pandiyan
75 M 1 112 62 2.2 138 4.2 145 207 negative 14.2 2.13 LVH
Lt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 0 3 0 3 0 0 0 0 0 7
25 20788 thangappan 62 M 1 213 37 1.1 141 4.3 162 217 negative 13.7 2.1 normal
rt 
capsulogangli
onic infarct
0 0 0 0 0 1 3 0 3 0 0 0 0 0 0 7
26 25319 somasundaram 48 M 1 201 44 1.4 145 4.6 171 234 negative 12.9 2.3 LVH
lt.capsulogan
glionic infarct
1 0 0 0 0 1 0 3 0 3 0 0 0 0 0 8
27 29983 rajendran 56 M 1 167 37 0.9 138 3.9 201 261 negative 13 2.43 LVH
lt.capsulogan
glionic infarct
1 0 0 0 0 1 0 3 0 3 0 0 1 0 0 9
28 47751 kasi 52 M 1 181 41 1.3 141 4.2 212 248 negative 12.7 2.11 normal
lt.capsulogan
glionic infarct
1 0 0 0 0 1 0 2 0 3 0 0 1 0 0 8
29 31860 arumugam 41 M 1 167 39 1.1 131 3.6 167 204 negative 10.8 1.98 normal
Lt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 0 3 0 3 0 0 0 0 0 7
30 27923
abubakar 
siddique
37 M 1 182 31 0.6 141 3.9 159 212 negative 11 2.14 normal
Lt capsulo 
ganglionic 
infarct
1 0 0 0 0 1 0 3 0 3 0 0 1 0 0 9
31 28980 subburaj 33 M 1 163 39 0.9 139 3.9 161 212 negative 13 2.32 normal
rt 
capsulogangli
onic infarct
0 0 0 0 0 1 2 0 2 0 0 0 0 0 0 5
32 33299 perumal 60 F 1 159 36 1.9 142 4.3 162 206 negative 12.7 2.21 LVH
Lt capsulo 
ganglionic 
infarct
1 0 0 0 0 1 0 3 0 3 0 0 0 0 0 8
33 30057 krishnan 70 M 1 197 46 1.4 145 3.8 181 233 negative 13.2 2.32 normal
Lt capsulo 
ganglionic 
infarct
1 0 0 0 0 1 0 2 0 3 0 0 0 0 0 7
34 10638 murugan 43 m 1 163 38 1.2 138 3.1 151 201 negative 14.1 2.13lakh normal
Lt capsulo 
ganglionic 
infarct
1 0 0 0 0 1 0 3 0 3 0 0 0 0 0 8
35 12049 samuthiram 63 M 1 171 41 1.3 145 4.6 162 216 negative 12.8 1.99 normal
Rt cerebellar 
infarct
0 0 0 0 0 0 0 0 0 0 2 0 0 1 0 3
36 9041 kadar sherif 50 M 1 183 43 1.5 144 4.4 172 247 negative 11.6 2.43 normal
Rt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 3 0 3 0 0 0 0 0 0 7
37 10501 paramasivan 55 M 1 174 36 1.2 143 4.1 171 234 negative 12.5 1.99 normal
Rt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 3 0 3 0 0 0 0 0 0 7
38 36402 velasari 70 M 2 1 164 42 1 141 4 122 160 negative 13 2.31 normal
rt 
capsulogangli
onic infarct
0 0 0 0 0 1 2 0 2 0 0 0 0 0 0 5
39 33278 selvaraj 54 M 2 2 98 37 1.3 138 3.8 86 139 negative 12.2 2.1 normal
Lt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 0 2 0 2 0 0 0 0 0 5
40 25941 ganapathi 70 M 2 1 103 49 2.1 131 4.7 89 149 negative 10.2 1.89 LVH
Rt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 3 0 3 0 0 0 0 0 0 7
41 27901 paulraj 72 M 2 2 121 39 1.5 134 3.4 99 134 negative 11.2 2.11 normal
Lt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 0 3 0 3 0 0 0 0 0 7
42 27495 kalimuthu 66 M 2 2 108 29 0.9 141 3.8 94 129 negative 13.4 2.34 normal
lt.capsulogan
glionic infarct
0 0 0 0 0 1 0 2 0 2 0 0 0 0 0 5
43 30256 chelladurai 45 m 2 1 112 34 0.9 139 3.8 91 143 negative 14.2 2.43 normal
Lt capsulo 
ganglionic 
infarct
1 0 0 0 0 1 0 2 0 2 0 0 1 0 0 7
44 27913 gunasekar 50 M 2 2 104 28 0.8 141 4.1 89 134 negative 13.1 2.09 normal
Rt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 3 0 2 0 0 0 0 0 0 6
45 46549 jeyapal 40 M 2 2 100 31 0.9 143 4.1 78 139 negative 12.4 1.98 normal
Lt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 0 2 0 2 0 0 0 0 0 5
46 33372 subbiah 85 M 2 1 101 56 2.1 130 5 87 141 negative 10.1 1.76 LVH
Lt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 0 3 0 2 0 0 0 0 0 6
47 20759 perumal 56 M 2 1 89 43 1.3 140 4.1 91 152 negative 14.6 2.43 normal
Rt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 2 0 2 0 0 0 0 0 0 5
48 20736 sundara pandi 60 M 2 1 92 39 1.1 142 3.9 101 156 negative 13.2 2.4 normal
Rt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 2 0 3 0 0 0 0 0 0 6
49 43789 jesuraj 40 M 2 2 84 31 0.8 140 3.8 87 131 negative 13.9 2.11 normal
rt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 2 0 2 0 0 0 0 0 0 5
50 43752 murugan 49 M 2 1 92 39 0.9 139 4.1 99 149 negative 13.2 2.03 normal
Lt capsulo 
ganglionic 
infarct
0 0 0 0 0 1 0 3 0 3 0 0 0 0 0 7
